Vaishali Pharma (NSE:VAISHALI) Inventories, Finished Goods: ₹34.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:VAISHALI Vaishali Pharma Ltd NSE:VAISHALI
52 GF Score
Price ₹8.34
View Full Analysis

What is Vaishali Pharma Inventories, Finished Goods?

Vaishali Pharma NSE:VAISHALI -0.36% 52 Inventories, Finished Goods is ₹34.0 Mil as of Mar. 2026. GuruFocus rates NSE:VAISHALI with a GF Score™ of 52/100.

Vaishali Pharma's quarterly finished goods increased from Dec. 2024 (₹0.0 Mil) to Mar. 2025 (₹48.1 Mil) but then declined from Mar. 2025 (₹48.1 Mil) to Mar. 2026 (₹34.0 Mil).

Vaishali Pharma's annual finished goods increased from Mar. 2024 (₹3.8 Mil) to Mar. 2025 (₹48.1 Mil) but then declined from Mar. 2025 (₹48.1 Mil) to Mar. 2026 (₹34.0 Mil).

Vaishali Pharma Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Vaishali Pharma's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaishali Pharma Inventories, Finished Goods Chart

Vaishali Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.29 30.50 3.80 48.10 34.01

Vaishali Pharma Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 48.10 34.01
NSE:VAISHALI
52GF Score
Vaishali Pharma Ltd NSE:VAISHALI
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaishali Pharma Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of ₹34.0 Mil mean?
Vaishali Pharma (NSE:VAISHALI) has a Inventories, Finished Goods of ₹34.0 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Vaishali Pharma and its competitors.
Is Vaishali Pharma's Inventories, Finished Goods too high?
Vaishali Pharma's current Inventories, Finished Goods is ₹34.0 Mil. Overall, Vaishali Pharma has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Vaishali Pharma's Inventories, Finished Goods compare to ZTS?
Vaishali Pharma's Inventories, Finished Goods of ₹34.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Vaishali Pharma and its competitors. Vaishali Pharma's current Inventories, Finished Goods is ₹34.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaishali Pharma stock overvalued right now?
Vaishali Pharma (NSE:VAISHALI) has a current Inventories, Finished Goods of ₹34.0 Mil. The current Inventories, Finished Goods is ₹34.0 Mil. Vaishali Pharma's overall GF Score™ is 52/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Vaishali Pharma (NSE:VAISHALI), the current Inventories, Finished Goods is ₹34.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vaishali Pharma Business Description

Address R.C. Patel Road, Off Sodawala Lane, 706-709, 7th Floor, Aravalli Business Center, Borivili (West), Mumbai, MH, IND, 400092
Vaishali Pharma Ltd is a pharmaceutical company. The Company is engaged in the marketing of pharmaceutical products including active pharmaceutical ingredients.
52GF Score

Get the complete analysis for NSE:VAISHALI

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8.34
Price